Growth failure and treatment in cystic fibrosis
Trang N Le1, Abeer Anabtawi2, Melissa S Putman3
1Departments of Internal Medicine and Pediatrics, Division of Endocrinology, Virginia Commonwealth University, Richmond, VA, USA.
Insights
Cystic fibrosis (CF) impacts growth, with height lagging behind weight gains despite improved care. New insights into CFTR
Area of Science:
- Pediatric Endocrinology
- Pulmonology
- Genetics
Background:
- Poor growth is a hallmark of cystic fibrosis (CF), impacting lung function and overall health.
- While nutrition and pulmonary care have improved weight gain in CF patients, height deficits persist, especially in those with severe CFTR mutations.
- The chronic inflammatory state in CF affects the growth hormone-IGF-1 axis and bone development.
Purpose of the Study:
- To review the factors influencing growth in cystic fibrosis patients.
- To explore the role of CFTR in bone health and the potential of CFTR modulators for growth.
- To discuss current and emerging treatments for growth deficits in CF.
Main Methods:
- Literature review of studies on growth in cystic fibrosis.
- Analysis of factors affecting the growth hormone-IGF-1 axis and bone growth in CF.
- Examination of the impact of CFTR mutations and modulators on growth outcomes.
Main Results:
- Height gains have not kept pace with weight improvements in children with CF.
- Severe CFTR mutations are associated with more significant growth impairments.
- Emerging data suggest direct effects of CFTR on bone, with implications for CFTR modulator therapies.
Conclusions:
- Optimizing growth in CF requires addressing multifactorial influences, including inflammation and CFTR function.
- CFTR modulators may offer new avenues for improving growth in cystic fibrosis.
- Further research is needed to fully understand and treat growth deficits in CF.
Abstract:
Poor growth has long been a characteristic feature of cystic fibrosis (CF) and is significantly linked to lung function and overall health status. Improvements in pulmonary and nutrition care for patients with cystic fibrosis (CF) have resulted in better growth outcomes; however, height gains have not paralleled the improvements in weight in children with CF, and patients with more severe CF mutations remain significantly more affected. Many factors affect the growth hormone-IGF-1 axis and the growth plate of the long bones, including the chronic inflammatory state associated with CF. There are also increasing data on the direct effects of CFTR on bone and implications for CFTR modulators in attaining optimal growth. Treatments aimed at improving growth in CF are also reviewed here.
More Related Videos
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Nature and Nurture
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Cells Coordinate Growth and Proliferation
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
